Insufficient scRNA-seq data for expression of GAL3ST3 at single-cell level.
Insufficient scRNA-seq data for expression of GAL3ST3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 681.37 | 2540 / 2642 | 98% | 9.08 | 690 / 705 |
thymus | 100% | 1881.32 | 653 / 653 | 91% | 20.11 | 550 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.11 | 1 / 1 |
uterus | 69% | 298.51 | 117 / 170 | 15% | 1.84 | 67 / 459 |
kidney | 60% | 201.36 | 53 / 89 | 13% | 0.80 | 117 / 901 |
heart | 68% | 294.27 | 585 / 861 | 0% | 0 | 0 / 0 |
ovary | 6% | 6.88 | 11 / 180 | 53% | 8.74 | 229 / 430 |
prostate | 39% | 70.57 | 96 / 245 | 3% | 0.10 | 17 / 502 |
esophagus | 23% | 41.69 | 332 / 1445 | 1% | 0.05 | 2 / 183 |
blood vessel | 22% | 31.28 | 290 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 9% | 10.57 | 31 / 328 | 1% | 0.07 | 1 / 178 |
adrenal gland | 0% | 0.65 | 1 / 258 | 2% | 0.07 | 4 / 230 |
muscle | 2% | 2.16 | 14 / 803 | 0% | 0 | 0 / 0 |
skin | 0% | 0.04 | 1 / 1809 | 1% | 0.05 | 7 / 472 |
lung | 0% | 0.88 | 2 / 578 | 1% | 0.04 | 11 / 1155 |
eye | 0% | 0 | 0 / 0 | 1% | 0.26 | 1 / 80 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.07 | 4 / 504 |
liver | 0% | 0.61 | 1 / 226 | 0% | 0 | 0 / 406 |
breast | 0% | 0.21 | 1 / 459 | 0% | 0.00 | 1 / 1118 |
adipose | 0% | 0.14 | 2 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0005996 | Biological process | monosaccharide metabolic process |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0006790 | Biological process | sulfur compound metabolic process |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0030309 | Biological process | poly-N-acetyllactosamine metabolic process |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016020 | Cellular component | membrane |
GO_0050656 | Molecular function | 3'-phosphoadenosine 5'-phosphosulfate binding |
GO_0050698 | Molecular function | proteoglycan sulfotransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0001733 | Molecular function | galactosylceramide sulfotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0050694 | Molecular function | galactose 3-O-sulfotransferase activity |
Gene name | GAL3ST3 |
Protein name | Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3) |
Synonyms | |
Description | FUNCTION: Transfers a sulfate to position 3 of non-reducing beta-galactosyl residues in N-glycans and core2-branched O-glycans. Has high activity towards Gal-beta-1,4-GlcNAc, Gal-beta-1,4(Fuc-alpha-1,3)GlcNAc and lower activity towards Gal-beta-1,3(Fuc-alpha-1,4)GlcNAc. . |
Accessions | ENST00000527878.1 Q96A11 ENST00000312006.5 |